Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Flyer

Archives of Clinical Microbiology

  • ISSN: 1989-8436
  • Journal h-index: 24
  • Journal CiteScore: 8.01
  • Journal Impact Factor: 7.55
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Google Scholar citation report
Citations : 2234

Archives of Clinical Microbiology received 2234 citations as per Google Scholar report

Flyer image
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • Open Archive Initiative
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Scimago Journal Ranking
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
View More
Share This Page

In silico prediction of immunogenic t cell epitopes of Leishmania donovani GP63 protein: an alternative approach for anti-parasite vaccine development

10th Edition of International Conference on Advanced Microbiology & Education
June 14-16, 2018 London, UK

Mona E. E. Elfaki Anne S De Groot, Andres H Gutierrez, Brema M Younis, Rayan Tassone, Francis Terry, Ahmed M Musa, Ahmed M Elhassan and Eltahir A G Khalil

University of Khartoum, Sudan Institute for Immunology and Informatics - University of Rhode Island, USA EpiVax Inc, USA King Khalid University, KSA

Posters & Accepted Abstracts: Arch Clin Microbiol

Abstract:

Visceral leishmaniasis (VL) is a major parasitic childhood disease in sub-Saharan Africa. Expensive and toxic antileishmanial drugs are current control methods. Safe, effective and cheap vaccines are potentially powerful strategies to control VL. Traditional vaccine development techniques have failed to deliver an effective vaccine. Leishmania vaccine development may benefit from immunoinformatics tools. This paper describes an improved in silico prediction method for immunogenic Leishmania donovani GP63 protein t cell epitopes as VL candidate vaccines. Using the EpiMatrix algorithm, the amino acid sequence of Leishmania donovani GP63 protein (GenBank accession: ACT31401) was screened for putative t cell cluster epitopes that would bind to the most common HLA (human leukocyte antigen) class II alleles among at-risk populations. Nine epitopes were initially identified using EpiMatrix. Based on cluster score, number of EpiMatrix hits, hydrophobicity, and number of EpiBars (an EpiBar is a 9 amino acid frame predicted to bind at least 4 different HLA molecules), four peptides (P1-P4) were selected for synthesis. In a proof of concept study, blood samples from consenting healthy, leishmanin skin test (LST) reactive and non-reactive volunteers were stimulated and IFN-γ, (Interferon gamma) IL-4 (Interleukin 4), and IL-10 were measured. IFN-γ and IL-4 levels were similar in both groups. However, mean IL-10 levels were significantly reduced in LST reactive individuals. To evaluate whether cross-reactivity with the human genome (HG), the human gut microbiome (HM) and common human pathogens (HP) was responsible for these differences, the sequences of the evaluated peptides were screened using JanusMatrix. One of the peptides (P1), which increased IL-10 in the LST reactive volunteers, showed high cross-reactivity with HG, suggesting that P1 might induce a regulatory immune response in humans. In conclusion, immunoinformatics tools provide a promising alternative approach for anti-parasite vaccine development. Data obtained can be used in the development of epitope-based Leishmania vaccine.

PDF HTML